Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro
Triple-negative breast cancer (TNBC) is one of the most aggressive types of cancer, and treatment is limited to chemotherapy and radiation. Oncolytic virotherapy may be a promising approach to treat TNBC. However, oncolytic adenovirus (OAd)-based mono-therapeutic clinical trials have resulted in mo...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
Molecular Diversity Preservation International
2018
|
| Materias: | |
| Acceso en línea: | http://eprints.uanl.mx/16244/1/148.pdf |